OP-005 Assessment of Warfarin TTR (Time in Therapeutic Range ) Results in a tertiary Reference Center

OP-005 Assessment of Warfarin TTR (Time in Therapeutic Range ) Results in a tertiary Reference Center

Anticoagulant drugs (warfarin, UFH and LMWH, and direct thrombin and factor Xa inhibitors) routinely used for the prevention of thromboembolism in patients with nonvalvular AF, mechanical heart valves, deep venous thrombosis, intracavitary thrombus.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2015-03, Vol.115, p.S2-S3
Hauptverfasser: Tekkesin, Ahmet Ilker, Cakilli, Yasin, Turkkan, Ceyhan, Demir, Koray, Borklu, Edibe Betul, Yildirimturk, Ozlem, Cinier, Goksel, Alper, Ahmet Taha
Format: Artikel
Sprache:eng
Schlagworte:
Anticoagulants
Cardiovascular
Drug therapy
Thrombosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Anticoagulant drugs (warfarin, UFH and LMWH, and direct thrombin and factor Xa inhibitors) routinely used for the prevention of thromboembolism in patients with nonvalvular AF, mechanical heart valves, deep venous thrombosis, intracavitary thrombus.
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2015.01.051